Cargando…
Healthcare value of implementing hepatitis C screening in the adult general population in Spain
BACKGROUND: Elimination of hepatitis C virus (HCV) infection requires high diagnostic rates and universal access to treatment. Around 40% of infected individuals are unaware of their infection, which indicates that effective screening strategies are needed. We analyzed the efficiency (incremental co...
Autores principales: | Buti, María, Domínguez-Hernández, Raquel, Casado, Miguel Ángel, Sabater, Eliazar, Esteban, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261617/ https://www.ncbi.nlm.nih.gov/pubmed/30485377 http://dx.doi.org/10.1371/journal.pone.0208036 |
Ejemplares similares
-
Clinical and economic value of sofosbuvir-based regimens in the treatment of chronic hepatitis C in Spain
por: Esteban, Rafael, et al.
Publicado: (2022) -
Is the universal population Hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence
por: Ledesma, Francisco, et al.
Publicado: (2020) -
Impact of the COVID-19 pandemic on HCV elimination in Spain
por: Buti, Maria, et al.
Publicado: (2021) -
Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
por: Sanchez-de la Rosa, Rainel, et al.
Publicado: (2013) -
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone(®)) in Spain
por: Martinez-Raga, Jose, et al.
Publicado: (2012)